- Academic Registry
Programme & Unit Catalogues

PA500386: Respiratory therapeutics

[Page last updated: 03 August 2022]

Academic Year: 2022/23
Owning Department/School: Department of Pharmacy & Pharmacology
Credits: 15 CATS credits
Notional Study Hours: 150
Level: FHEQ level 7
Modular (no specific semester)
Assessment Summary: PF 100%
Assessment Detail:
  • Clinical & Work Based Portfolio (PF 100%)
Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Learning Outcomes:
* Critically analyse and evaluate the pathophysiology of a range of respiratory disorders, the pharmacology of key medicines, and apply these to support optimisation of therapeutic selection, administration and monitoring in these conditions
* Use effective communication strategies to support patients (and carers, advocates, representatives) and healthcare professionals to make medicines optimisation decisions; taking into account patient views/beliefs/ICE (ideas, concerns, expectations)
* Identify, critically evaluate and apply key evidence sources in order to effect medicines optimisation outcomes within these clinical conditions
* Identify and employ effective patient activation strategies to support patients with these conditions
* Design enhancements to medicines and health services, including effective use of health resources, patient facing services and clinical governance structures
* Reflect on learning experiences, evaluate performance, and identify performance gaps within this clinical area to support ongoing development.

Aims: To update the underpinning knowledge of pharmacology, pathophysiology and medicines optimisation to support the clinical management of patients with respiratory conditions.

* Clinical skills
* Study skills
* Written communication
* Working with others
* Scientific and practical skills
* Improving learning and performance
* Information and communication technology
* Problem solving.

* Pathophysiology of key conditions including:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Non-CF Bronchiectasis
- Pleural Lung Conditions
- Cystic Fibrosis & Bronchiectasis
- Pulmonary Embolism
- Pulmonary Hypertension
* Pharmacology, administration and monitoring of medicines used in the treatment of these conditions, including drug delivery to the lungs
* Drug-disease interactions specific to these conditions
* Pharmacoeconomic consideration of medicines optimisation
* Professional and ethical values
* Communication, negotiating and agreeing healthcare decisions
* Additional skills to support the delivery of enhancements to medicines and health services, including effective use of health resources, patient facing services and clinical governance structures.

Programme availability:

PA500386 is Optional on the following programmes:

Department of Pharmacy & Pharmacology


  • This unit catalogue is applicable for the 2022/23 academic year only. Students continuing their studies into 2023/24 and beyond should not assume that this unit will be available in future years in the format displayed here for 2022/23.
  • Programmes and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Find out more about these and other important University terms and conditions here.